BUTMAC Research Activities
The BUTMAC has an ongoing registry and bio bank where clinical and laboratory data could be collected over a long period of time from patients with TMA. The collected information could be used to better understand the cause and the underlying pathophysiology of TMA. Genetic data could be used to better understand the underlying gene mutations or predisposing genes that lead to the development of TMA.
Our center participates in clinical trials that aim to study the efficacy and the safety of new medications used for the treatment of TMA. We are currently participating in one clinical trial at BUTMAC. To learn about this trial, please contact Dr. Jean Francis at Jean.Francis@bmc.org and Dr. Vipul Chitalia at Vipul.Chitalia@bmc.org.
The samples derived from TMA patients are used to examine the mechanisms promoting the TMA-assocaited phenotypes in a hypothesis-driven fashion. This part of the research is overseen by Drs. Vipul Chitalia, Katya Ravid and David Salant.
The success of our clinical mission and research endeavor are only possible with the dedication and the contribution of our patients, their families and friends. TMA remains an extremely rare disease and very difficult to diagnose. We are dedicated to advance the understanding of TMA and improve our patients’ outcome.